Imidoca dipropionate is a propionate of imidazobenlurea, which is a new type of antigenic worm chemical drug for animals. It is generally made of dipropionate or dihydrochloride in clinical practice and injected through muscle or subcutaneous. It is used to treat and prevent various diseases caused by Babesiosis, piriformis, Trypanosoma, erythrosoma, limbic worm and Thaleria. In the prior art, imidoca dipropionate is a non-sterile raw material, and the preparation method is recrystallization after synthesis of imidazophenylurea and propionic acid in different organic solvents. In this method, a large number of organic solvents are required, and a large number of recrystallized mother liquor causes a large amount of product loss, and the solvent recovery energy is high. With the discovery of new clinical uses of imidoca dipropionate, such as the preparation method of the long-acting preparation of imidoca dipropionate for animal use and the preparation method of the compound preparation of imidoca dipropionate for animal use for eperythrozoonosis. It is more difficult to prepare compound preparations with non-sterile imidoca dipropionate.

Application:

1 Imidocarb is an antiprotozoan agent used as a dipropionate in the treatment of Babesiosis and Ehrlich's disease.

2 It is suitable for all kinds of diseases caused by Babesia, pyriformis, Trypanosoma, erythrosoma, limbic worm and Tayloria.